The Methylmalonic Acidemia (MMA) Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Methylmalonic Acidemia (MMA) Market?
The market size of methylmalonic acidemia (MMA) has experienced strong growth recently. It is projected to increase from $9.39 billion in 2024 to $9.97 billion in 2025, with a CAGR of 6.2%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Methylmalonic Acidemia (MMA) Industry?
The Methylmalonic Acidemia (MMA) market is forecasted to grow to $12.50 billion by the year 2029. The projected compound annual growth rate (CAGR) is expected to be 5.8%.
Download Your Free Sample of the 2025 Methylmalonic Acidemia (MMA) Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Methylmalonic Acidemia (MMA) Market?
The key drivers in the methylmalonic acidemia (mma) market are:
• Increasing newborn screening programs
• Increased awareness among healthcare professionals
• Rise in gene therapy advancements
• Increasing investments in rare disease research
Global Market Segmentation: Identifying Major Methylmalonic Acidemia (MMA) Industry Segments
The methylmalonic acidemia (MMA) market covered in this report is segmented –
1) By Indication: Acidosis, Ketosis, Hyperammonemia, Hypoglycaemia, Hyperglycaemia, Neutropenia, Other Indications
2) By Disorder Type: Homocystinuria, Isolated Methylmalonic Acidurias, Combined methylmalonic Aciduria
3) By Distribution Channel: Hospitals, Pharmacies, Clinics, Other Distribution Channels
Subsegments:
1) By Acidosis: Metabolic Acidosis, Lactic Acidosis
2) By Ketosis: Starvation-Induced Ketosis, Diabetic Ketoacidosis
3) By Hyperammonemia: Acute Hyperammonemia, Chronic Hyperammonemia
4) By Hypoglycemia: Fasting Hypoglycemia, Reactive Hypoglycemi
5) By Hyperglycemia: Transient Hyperglycemia, Persistent Hyperglycemia
6) By Neutropenia: Severe Neutropenia, Cyclic Neutropenia
7) By Other Indications: Failure to Thrive, Developmental Delays, Neurological Symptoms, Renal Dysfunction
Pre-order the 2025 Methylmalonic Acidemia (MMA) Global Market Report for Fast Delivery & Comprehensive Insights!
What are the emerging Trends Shaping the Future of the Methylmalonic Acidemia (MMA) Market?
The key trends in the methylmalonic acidemia (mma) market are:
• Advancements in gene editing technologies are shaping the future of the MMA market.
• The market is being influenced by more advanced diagnostic methods that allow for early detection.
• There is a growing trend towards enzyme replacement therapies.
• The adoption of precision medicine approaches and newborn genetic screening programs are significant trends.
Who Are the Top Competitors & Leading Players in the Methylmalonic Acidemia (MMA) Market?
Major players in the methylmalonic acidemia (mma) market are:
• Moderna Inc.
• Lonza Group Ltd.
• Alexion Pharmaceuticals Inc.
• PTC Therapeutics Inc.
• Ironwood Pharmaceuticals Inc.
• Wockhardt Limited.
• Spectrum Chemical Manufacturing Corp.
• Asklepios BioPharmaceutical Inc. (AskBio)
• Selecta Biosciences Inc.
• BTG International Inc.
• BridgeBio Pharma Inc.
• VectivBio Holding AG
• Supriya Lifescience Ltd.
• Recordati Rare Diseases Inc.
• Agios Pharmaceuticals Inc.
• AdvaCare Pharma USA LLC
• LogicBio Therapeutics Inc.
• HemoShear Therapeutics LLC
• Manus Aktteva Biopharma LLP
• Deccan Nutraceuticals Pvt. Ltd.
Regional Dominance: Which Area Leads the Global Template Market?
North America was the largest region in the methylmalonic acidemia (MMA) market in 2024
